VEGFA and cervical squamous cell carcinoma: VEGF family proteins and receptors also play a crucial role in tumor angiogenesis, and bevacizumab, an anti-VEGF monoclonal antibody, is used in the treatment of cervical squamous cell carcinoma (SCC) [11].